2-脱氧-2-[18F]氟-D-葡萄糖正电子发射断层显像/计算机断层显像的体积参数可预测胰腺腺癌新辅助放化疗后的组织病理学治疗反应
本研究纳入25例接受吉西他滨和S-1为基础术前放化疗后根治性手术的胰腺腺癌患者,用FDG PET/CT评估体积参数与Evans分级组织病理学反应的关系。反应者放化疗后SULpeak显著低于非反应者(p=0.013),6例反应者放化疗后MTV和TLG均为阴性,列联表分析显示放化疗后MTV和TLG状态在反应者与非反应者间差异有统计学意义(两者p=0.014)。
要点
- 放化疗后SULpeak较高、MTV/TLG阳性可能预测胰腺腺癌放化疗组织病理学反应不佳。
- 6例反应者放化疗后MTV和TLG均为阴性,与非反应者差异有统计学意义(p=0.014)。
- 反应者放化疗后SULpeak显著低于非反应者(p=0.013)。
核心结论
- 体积PET/CT参数中,治疗后较高的SULpeak以及MTV/TLG阳性可预测胰腺腺癌放化疗的不利组织病理学效应。
研究设计与样本
- 研究纳入25例胰腺腺癌患者,均接受吉西他滨和S-1为基础术前放化疗后根治性手术,以Evans分级系统评估残余肿瘤程度。
诊断标准与关键数值
- 以Evans分级系统评估残余肿瘤,肿瘤细胞破坏超过50%定义为反应者;反应者6例(24%),非反应者19例(76%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The purpose of this study was to investigate the clinical potential of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography (FDG PET/CT) to evaluate histopathologic effects of preoperative chemoradiotherapy (CRT) in pancreatic adenocarcinoma, with particular focus on volumetric PET/CT parameters.
MATERIAL AND METHODS: This study included 25 patients with pancreatic adenocarcinoma who underwent radical surgery after gemcitabine- and S-1-based preoperative-CRT. The extent of residual tumor was graded using the Evans grading systems, and patients with more than 50% destruction of tumor cells were defined as responder. Peak SUV corrected for lean body mass (SULpeak), metabolic tumor volume (MTV) with a threshold of SUV=2.0, total lesion glycolysis (TLG) of pre- and post-CRT, and reduction rates of SULpeak in those parameters were assessed by PET/CT. These parameters were compared using the student's t-test between responder and non-responder. The treatment effect was also assessed by contingency table analysis divided with median value of each parameter using chi-square tests.
RESULTS: Eight patients (32%) showed histopathologic poor response (Evans grade I), 11 cases (44%) had mild response (Evans grade IIa), and six cases (24%) had moderate response (Evans grade IIb); therefore, six cases (24%) were assigned to responders and others 19 cases (76%) were non-responders. With regards to volumetric PET parameters, post-CRT SULpeak of responders was significantly lower than that of non-responders (p=0.013). Post-CRT MTV and TLG were negative for all six cases of responders. There were significant differences between responder and non-responder on the contingency table analysis of post-CRT MTV and TLG status (p=0.014 for both).
CONCLUSIONS: This study demonstrated that the volumetric PET/CT parameters, higher post-treatment SULpeak and positive MTV/TLG could predict the unfavorable histopathological effects of CRT in patients with pancreatic adenocarcinoma.
引用
- Sakane M, Tatsumi M, Hori M, et al. Volumetric parameters of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography can predict histopathologic treatment response after neoadjuvant chemoradiotherapy in pancreatic adenocarcinoma. Eur J Radiol. 2017. PMID: 28712692. doi:10.1016/j.ejrad.2017.05.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。